Abstract |
Lowe syndrome is a lethal X-linked genetic disorder characterized by congenital cataracts, mental retardation, and kidney dysfunction. It is caused by mutations in the OCRL1 ( oculocerebrorenal syndrome of Lowe) gene that encodes a phosphatidylinositol 5-phosphatase (EC 3.1.3.36). The gene product Ocrl1 has been linked to a multitude of functions due to the central role played by phosphoinositides in signaling. Moreover, this protein also has the ability to bind Rho GTPases, the master regulators of the actin cytoskeleton, and to interact with elements of the vesicle trafficking machinery. It is currently under investigation how deficiencies in Ocrl1 affect these different processes and contribute to patient symptoms. This chapter outlines the known physiological roles of Ocrl1 which might be relevant to the mechanism underlying Lowe syndrome.
|
Authors | Kayalvizhi Madhivanan, Swetha Ramadesikan, R Claudio Aguilar |
Journal | International review of cell and molecular biology
(Int Rev Cell Mol Biol)
Vol. 317
Pg. 331-47
( 2015)
ISSN: 1937-6448 [Print] Netherlands |
PMID | 26008789
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
- Phosphoric Monoester Hydrolases
- OCRL protein, human
- Ocrl protein, mouse
|
Topics |
- Animals
- Cilia
(physiology)
- Humans
- Oculocerebrorenal Syndrome
(metabolism, pathology)
- Phosphoric Monoester Hydrolases
(metabolism)
|